comparemela.com
Home
Live Updates
Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHA
Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHA
Oncolytics Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 MANAGEMENT INFORMATION CIRCULAR - Form 6-K
NOTICE OF ANNUAL GENERAL MEETING
OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024
- AND -
MANAGEMENT INFORMATION CIRCULAR
...
Related Keywords
Germany ,
University Of Dayton ,
Ohio ,
United States ,
Louisiana ,
Massachusetts ,
Guelph ,
Ontario ,
Canada ,
New Jersey ,
Munich ,
Bayern ,
Toronto ,
United Kingdom ,
Ireland ,
Michigan ,
Pennsylvania ,
Calgary ,
Alberta ,
New York ,
Princeton University ,
Irish ,
Canadian ,
American ,
Canadians ,
America ,
Sanofi Pasteur ,
Angela Holtham ,
Laurel Hill ,
Broadridge Quickvote ,
Deborahm Brown ,
Thomasc Heineman ,
Jamest Parsons ,
Aptose Biosciences ,
Matthewc Coffey ,
Amyg Levin ,
Matt Coffey ,
Berndr Seizinger ,
Bernd Seizinger ,
Bristol Myers Squibb ,
Patricia Andrews ,
Allison Hagerman ,
Wayne Pisano ,
Revolo Biotherapeutics ,
Jonathan Rigby ,
Michael Bennett ,
James Parsons ,
Deborah Brown ,
Altimmune Inc ,
Global Head Of Clinical Development ,
Member Of The Compensation Committee ,
National Pharmaceutical Organization ,
Glycomimetics Inc ,
Member Of The Audit Committee ,
United Therapeutics Corporation ,
National Instrument ,
Laws Of The Corporation ,
Broadridge Financial Solutions Inc ,
Sheffield University ,
Us Exchange ,
John Fisher College ,
Rotman School Of Management ,
Toronto Stock Exchange ,
Management Of The Corporation ,
Compensation Committee ,
Serono ,
Common Shares Of The Corporation ,
Nasdaq ,
Sumitomo Pharma Oncology Inc ,
University School Of Business ,
Corporation Management ,
University Of Guelph ,
Amorfix Life Sciences Ltd ,
Member Of The Science Development Committee ,
Diamedica Therapeutics Inc ,
Sumitomo Pharma Co Ltd ,
Trillium Therapeutics Inc ,
Member Of The Governance Committee ,
Exchange Act Rule ,
United States Securities Exchange ,
Audit Committees Of Sernova Corp ,
Governance Committee ,
Science Development ,
Corporation At Suite ,
Articles Of Incorporation The Corporation ,
University Of Calgary ,
Institute Of Corporate Directors Designation ,
Corporation Stock Option Plan ,
Oncolytics Biotech Inc ,
Bioplus Acquisition Corp ,
Trust Company ,
Governance Or Science Development Committee ,
Pfizer ,
Rigby ,
Aprea Therapeutics Inc ,
Portsmouth University ,
Laurel Hill Advisory Group ,
Peer Group ,
Nabisco Inc ,
Corporation Board Of Directors The Peer Group ,
Bioinvent International ,
Technology Committee ,
Steadymed Ltd ,
Science Development Committee ,
Harvard Medical School ,
Zogenix Inc ,
Business Development ,
Opsona Therapeutics Ltd ,
Audit Committee ,
Health Care Index ,
Brown University ,
University Of Toronto ,
Sernova Corp ,
University Of Michigan ,
Honors In Biological Sciences ,
Product Development ,
Novartis ,
Officers Of The Corporation ,
Clinical Development ,
Aptose Biosciences Inc ,
Aon Company Radford ,
Number Of Directors The Corporation ,
Annual Meeting ,
Special Meeting ,
Management Information Circular ,
Investor Relations ,
Management Information ,
Chief Executive Officer ,
Oncolytics Biotech ,
Annual General Meeting ,
Registered Shareholder ,
Common Shares ,
Control Number ,
Toronto Time ,
North American Toll Free ,
Calls Outside North America ,
Beneficial Shareholder ,
Objecting Beneficial Owners ,
Non Objecting Beneficial Owners ,
Registered Shareholders ,
Beneficial Shareholders ,
United States Securities Exchange Act ,
Beneficial Owners ,
Reporting Issuer ,
Notice And Access Provisions ,
Canadian Securities Administrators ,
Broadridge Financial Solutions ,
Vote Your Common ,
Common Share ,
Record Date ,
Financial Statements ,
Auditor Report ,
Date Appointed ,
Principal Occupation ,
Preceding Five Years ,
Sumitomo Pharma Oncology ,
Global Head ,
Executive Officer ,
Executive Vice President ,
Chief Commercial Officer ,
Vice President ,
General Manager ,
Canadian Strategic Partnerships ,
Managing Director ,
Innovative Medicines Canada ,
Western University ,
Corporate Directors Designation ,
Human Gene Therapy ,
Chief Operating Officer ,
Chief Scientific Officer ,
Chief Financial Officer ,
Senior Vice President ,
Chief Financial ,
Ontario Based Hospital ,
Sick Children ,
Trillium Therapeutics ,
Lorus Therapeutics ,
Audit Committees ,
Diamedica Therapeutics ,
Group Chief Executive Officer ,
United Therapeutics ,
Profile Therapeutics ,
Phillips Medical ,
Immunomolecular Therapeutics Board ,
Biological Sciences ,
Oncology Drug Discovery ,
Academic Alliances ,
Massachusetts General ,
Aprea Therapeutics ,
Nykode Therapeutics ,
Majority Voting Policy ,
Cease Trade Orders ,
Chartered Accountants ,
Stock Option Plan ,
Share Award Plan ,
Compensation Framework ,
Aon Company ,
Named Executive Officer ,
Named Executive Officers ,
Share Awards ,
Erroneously Awarded Incentive Based Compensation ,